beta-galactosidase, N-acetylgalactosamine-6-sulfatase
Morquio Syndrome (MPS IV) Enzyme Panel
Key Information
Lab:
TAT:
14 days
Price:
$400
CPT Code(s):
82657x2
Test Code:
BMQP, BMQD
Morquio Syndrome (MPS IV) Enzyme Panel
This panel measures the activity of 2 enzymes in patients with a diagnosis or clinical suspicion of Morquio syndrome (Mucopolysaccharidosis IV, MPS IV). Enzyme analysis for each type of Morquio syndrome can be ordered individually or as a panel. Because Morquio type A and GM1 gangliosidosis, Morquio B can have significant clinical overlap, enzyme analysis is necessary to distinguish between the two. These enzymes are required for the modification and removal of keratan sulfate.
Morquio syndrome A (MPS IVA), GM1 gangliosidosis (Morquio B)
Clinical Information
Morquio syndrome is characterized by short stature and trunk, large head, mildly coarse facies, widely spaced teeth, corneal clouding, a bell-shaped chest, vertebral anomalies, joint stiffness and kyphoscoliosis. Other features may include inguinal hernia, hepatomegaly and hearing loss. There is a wide spectrum of those affected ranging from mild to severe. There is typically no cognitive impairment.
Technical Information
Enzyme activity is measured using a 4-methylumbelliferyl (4-MU) substrate and liquid chromatography-tandem mass spectrometry (LC-MS/MS) (DBS).
Specimen Requirements
Transport Instructions
Associated Tests
- GM1 Gangliosidosis, Morquio Syndrome B (MPS IVB): Beta-galactosidase Enzyme Analysis
- Morquio Syndrome (MPS IV): Urine Monitoring (Total GAGs, KS, CS)
- Morquio Syndrome A (MPS IVA): N-Acetylgalactosamine-6-Sulfatase Enzyme Analysis
- Mucopolysaccharidosis (MPS) Enzyme Panel
- Mucopolysaccharidosis (MPS) Enzyme Panel (DBS)
- Storage Disease Panel
- Total Glycosaminoglycans (GAGs) Analysis
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
